If glucose levels are very high SGLT2 inhibitors can result in marked polyuria and nocturia that leads to uncomfortable symptoms and therefore many clinicians do not initiate SGLT2 inhibitor therapy in patients with high HbA1c levels until glucose control is in a more reasonable range
58 Mitoses are infrequently observed, and necrosis is absent
J Biol Chem 270:2648826496 Sharma D, Verma S, Vaidya S, Kalia K, Tiwari V (2018) Recent updates on GLP-1 agonists: current advancements & challenges
Prescribing decisions for older patients must be individualised, considering factors such as frailty, comorbidities, nutritional status, and potential benefits versus risks
Addressing imbalances in these systems creates a physiological environment that supports tissue repair and improves responsiveness to peptide therapy